Search the Newsreel

Arcturus (ARCT) Q2 2026 Earnings Call Transcript

HC Wainwright Has Optimistic Outlook of ARCT Q3 Earnings

RedCloud Signs India MOUs to Deploy Its RAID and CORE Engines Targeting 11 Apparel Brands, 25,000+ SKUs and 1,250+ Buyer Points

RedCloud Holdings plc announced two Memoranda of Understanding (MOUs) to deploy its RedAI infrastructure, powered by RAID and CORE engines, across the apparel, footwear, and lifestyle distribution operations of Dheer Marketing India Pvt. Ltd. and Klakshya Marketing Private Limited in India. These programs aim …

RedCloud’s India programs target 11 brands and 1,250+ buyer points

RedCloud (Nasdaq: RCT) announced two Memoranda of Understanding (MOUs) to deploy its RedAI infrastructure, including RAID and CORE engines, with Dheer Marketing India and Klakshya Marketing. These MOUs target 11 apparel and footwear brands, over 25,000 active SKUs, and more than 1,250 buyer points …

Arcturus Therapeutics Eyes Phase III CF Call, OTC Data as Vaccine Funds Pipeline

Arcturus Therapeutics is focusing its mRNA platform on rare diseases like cystic fibrosis (CF) and ornithine transcarbamylase (OTC) deficiency, utilizing its vaccine business to fund these therapeutic developments. The company expects to decide on advancing its inhaled mRNA treatment for CF (ARCT-032) into Phase …

H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Hold Rating, Maintains Target Price $9

H.C. Wainwright has reiterated its Hold rating on Arcturus Therapeutics (ARCT.US) and maintained its target price at $9. This indicates that the firm sees the stock as likely to perform in line with the broader market and does not anticipate significant price movement from …

Why High Arctic Energy Services Inc. stock is rising today

Reef Casino Director Sells Entire Stake as Iris Cairns Takeover Advances

Arcturus Therapeutics (NASDAQ:ARCT) Rating Increased to Sell at Wall Street Zen

Wall Street Zen upgraded Arcturus Therapeutics (ARCT) from "strong sell" to "sell," while Weiss Ratings maintained its "sell (D-)" rating. Despite these downgrades, MarketBeat's analyst consensus remains a "Moderate Buy" with an average price target of $24.25. The clinical-stage biotech company, which develops mRNA …

RedCloud Holdings PLC (RCT) Stock News Today

This page on TradingKey provides current stock news for RedCloud Holdings PLC (RCT), noting a slight increase of 1.36% to $0.209 USD. The platform indicates that more news will be coming soon, currently offering basic stock data and navigation options for further analysis.

Arcturus Therapeutics (NASDAQ:ARCT) Announces Earnings Results, Beats Estimates By $0.16 EPS

Arcturus Therapeutics (NASDAQ:ARCT) announced its quarterly earnings, reporting an EPS of ($0.84), beating analyst estimates by $0.16, despite revenue of $2.96 million falling short of expectations. The company provided updates on clinical trials for ARCT-810 and ARCT-032, and regained global rights to its KOSTAIVE …

Arcturus Therapeutics (ARCT) Stock Jumps As Cash Runway Reframes Pipeline Risk

Arcturus Therapeutics Holdings Inc. Stock 12‑Month Price Target Cut to $20.2, Implies 232% Upside

Arcturus Therapeutics Holdings Inc.'s average stock price target has been reduced from $20.6 to $20.2 by 10 analysts, still suggesting a significant 232% potential upside based on its closing price on August 6. Despite the target cut, the consensus rating from 13 analysts remains …

RedCloud Holdings PLC (RCT) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for RedCloud Holdings PLC (RCT), indicating a "Buy" trend based on ratings from three analysts. It highlights the current stock price, market cap, and offers a target price suggesting a significant upside. The report also includes a peer …

High Arctic lifts Q2 revenue on Duvernay rentals and Team Snubbing turnaround

High Arctic Energy Services Inc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW CALGARY, Alberta, Aug. 07, 2026 (GLOBE NEWSWIRE) -- High Arctic Energy Services Inc. (TSX: HWO) …

CCORF Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Cuts Target Price to $20

CCORF has reiterated its Buy rating for Arcturus Therapeutics (ARCT.US) but has adjusted its target price downwards to $20. This indicates a continued positive outlook on the stock, albeit with a revised valuation.

Arcturus Therapeutics Announces Second Quarter 2026 Financial Results and Pipeline Progress

Arcturus Therapeutics reported its Q2 2026 financial results and provided updates on its pipeline, including continued progress in the ARCT-032 Phase 2 cystic fibrosis study and completed enrollment for the ARCT-810 Phase 2 OTC deficiency study. The company regained global rights to KOSTAIVE® and …

Earnings call transcript: Arcturus Therapeutics tops Q2 2026 EPS view

Arcturus Therapeutics reported a narrower-than-expected loss for Q2 2026, beating EPS forecasts by 20%, but saw a significant revenue drop due to the conclusion of its CSL Seqirus collaboration. The company emphasized progress in its rare disease pipeline, including cystic fibrosis (ARCT-032) and ornithine …

RedCloud Holdings plc (RCT) latest press releases and corporate news

This article provides a compilation of RedCloud Holdings plc (RCT)'s recent press releases and corporate news. It highlights various strategic moves including new appointments, product launches, AI initiatives, joint ventures in emerging markets like India and Saudi Arabia, and financial updates. The company is …

Arcturus Therapeutics Holdings Inc. Q2 2026: Revenue $2.96M, EPS $(0.84) — 10-Q Summary

Arcturus Therapeutics Holdings Inc. (ARCT) reported its Q2 2026 financial results, with revenue of $2.96 million and a net loss of $23.79 million, resulting in a diluted loss per share of $(0.84). This decline in revenue is attributed to KOSTAIVE transitioning to commercial stages, …

RedCloud Holdings plc (RCT) latest stock news and headlines

This article provides a compilation of recent news and headlines concerning RedCloud Holdings plc (RCT), including updates on its AI strategy, new partnerships, key appointments, and global expansion efforts. It highlights the company's activities in signing AI leadership letters, appointing a new CFO, unveiling …

Why High Arctic Energy Services Inc. stock is skyrocketing today

Arcturus Therapeutics (ARCT) Reports Q2 Loss, Beats Revenue Estimates

Arcturus Therapeutics (ARCT) reported a Q2 loss of $0.84 per share, surpassing the Zacks Consensus Estimate of a $1.07 loss, and beat revenue estimates with $2.96 million. Despite underperforming the S&P 500 year-to-date, the company has exceeded EPS estimates in three of the last …

RedCloud Signs Open Weights and American AI Leadership Letter Alongside Microsoft, NVIDIA and OpenAI

RedCloud Holdings plc announced its co-signature of the Open Weights Letter, an industry commitment to open-weight AI models backed by major tech companies like Microsoft, NVIDIA, and OpenAI. RedCloud emphasizes that open-weight AI allows it to specialize advanced models on its proprietary FMCG trading …

RedCloud backs open-weight AI so customer trading data need not leave its environment

RedCloud has co-signed the Open Weights Letter, aligning with major tech companies like Microsoft and NVIDIA to support open-weight AI models. This move allows RedCloud to specialize advanced AI models on its proprietary $6.9 billion FMCG trading data within its own infrastructure, ensuring customer …

Arcturus Therapeutics: Q2 Earnings Snapshot

Iris Makes Reef Casino Takeover Bid Unconditional as Control Passes 80% Threshold

Why (ARCT) Price Action Is Critical for Tactical Trading

The article discusses the critical price action for Arcturus Therapeutics Holdings Inc. (ARCT) for tactical trading, highlighting a near-term strong sentiment that could challenge persistent mid and long-term weakness. It identifies an exceptional 394.0:1 risk-reward setup targeting a 90.6% gain versus 0.2% risk and …

Arcturus Therapeutics Holdings Inc expected to post a loss of 100 cents a share - Earnings Preview

Arcturus Therapeutics Holdings Inc (ARCT) is anticipated to report a loss of 100 cents per share in its upcoming earnings. This forecast is part of an earnings preview, suggesting investors and analysts are closely watching the company's financial performance. The full article provides more …

RedCloud Holdings PLC (RCT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of RedCloud Holdings PLC (RCT), focusing on its support, resistance, indicators, and moving averages. It details various technical indicators like MACD, RSI, KDJ, and ATR, along with their values and directional signals (Buy, Sell, Neutral). The article also …

Antarctica Ltd Revenue Breakdown – NSE:ANTGRAPHIC

High Arctic Energy Services Inc Revenue Breakdown – TSX:HWO